Indoco Remedies, 532612, INDOCO Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,062.29
95.52
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,852.05
0.45%
2.81

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.80
10.43
5.66

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.63
14.37
-6.24

PAT CAGR (%)

10 Years
5 Years
3 Years

1.75
32.49
-14.00

P:E (Median)

8 Years
5 Years
3 Years

29.84
29.67
24.73

P:BV (Average)

8 Years
5 Years
3 Years

3.30
3.50
3.26

EV:EBITDA (Average)

8 Years
5 Years
3 Years

15.53
15.42
12.96

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 10.68 6.27 14.2 20.6
P/E Ratio 28.6 48.77 21.53 14.83
Revenue 1791 1807 2078 2353
EBITDA 244 244 349 413
Net Income 98 82 151 190
ROA 6.4 0.5 3.7 7.1
P/Bk Ratio 2.54 2.44 2.21 2.03
ROE 9.21 4.9 10.77 14.4
FCFF -302.28 -61 58.5 113.7
FCFF Yield -8.52 -1.72 1.65 3.2

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 396.53 473.39 -16.24% 401.43 422.88 -5.07% 445.49 427.46 4.22% 449.05 398.64 12.65%
Expenses 343.66 400.97 -14.29% 349.86 359.97 -2.81% 388.13 363.29 6.84% 383.76 336.99 13.88%
EBITDA 52.87 72.42 -27.00% 51.57 62.91 -18.03% 57.36 64.17 -10.61% 65.29 61.65 5.90%
EBIDTM 13.33% 15.30% 12.85% 14.88% 12.88% 15.01% 14.54% 15.47%
Other Income 4.20 1.12 275.00% 3.52 0.41 758.54% 4.05 0.49 726.53% 2.93 0.37 691.89%
Interest 14.77 8.10 82.35% 11.88 7.78 52.70% 10.91 8.64 26.27% 10.03 7.01 43.08%
Depreciation 24.92 21.41 16.39% 23.70 19.87 19.28% 23.73 17.69 34.14% 22.97 17.16 33.86%
PBT 17.38 44.03 -60.53% 19.51 35.67 -45.30% 46.50 38.33 21.31% 27.02 37.85 -28.61%
Tax 4.59 10.89 -57.85% 4.56 9.73 -53.13% 8.94 12.96 -31.02% 7.01 9.98 -29.76%
PAT 12.79 33.14 -61.41% 14.95 25.94 -42.37% 37.56 25.37 48.05% 20.01 27.87 -28.20%
PATM 3.23% 7.00% 3.72% 6.13% 8.43% 5.94% 4.46% 6.99%
EPS 1.39 3.59 -61.28% 1.62 2.81 -42.35% 4.07 2.75 48.00% 2.17 3.02 -28.15%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 432.66 481.73 -10.19% 431.49 426.50 1.17% 449.64 428.16 5.02% 459.42 399.20 15.09%
Expenses 392.41 410.36 -4.37% 383.72 365.33 5.03% 400.77 363.40 10.28% 396.52 337.16 17.61%
EBITDA 40.25 71.37 -43.60% 47.77 61.17 -21.91% 48.87 64.76 -24.54% 62.90 62.04 1.39%
EBIDTM 9.30% 14.82% 11.07% 14.34% 10.87% 15.13% 13.69% 15.54%
Other Income 1.56 4.43 -64.79% 1.03 0.41 151.22% 2.66 0.50 432.00% 2.35 0.36 552.78%
Interest 17.83 8.11 119.85% 14.31 7.79 83.70% 12.05 8.64 39.47% 10.07 7.01 43.65%
Depreciation 28.82 21.41 34.61% 27.52 19.88 38.43% 26.23 17.69 48.28% 24.35 17.17 41.82%
PBT -4.84 46.28 - 6.97 33.91 -79.45% 32.98 38.93 -15.28% 22.63 38.22 -40.79%
Tax 5.17 11.04 -53.17% 5.15 9.73 -47.07% 10.95 13.12 -16.54% 7.07 10.07 -29.79%
PAT -10.01 35.24 - 1.82 24.18 -92.47% 22.03 25.81 -14.65% 15.56 28.15 -44.72%
PATM -2.31% 7.32% 0.42% 5.67% 4.90% 6.03% 3.39% 7.05%
EPS -1.04 3.81 - 0.29 2.65 -89.06% 2.46 2.80 -12.14% 1.77 3.05 -41.97%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,692.50 1,790.81 1,666.69 1,539.72 1,240.30 1,105.99 967.73 1,038.21 1,072.06 1,004.76 854.00 Net Sales Growth -1.73% 7.45% 8.25% 24.14% 12.14% 14.29% -6.79% -3.16% 6.70% 17.65% Cost Of Goods Sold 527.24 546.45 521.29 456.75 354.07 330.43 320.17 346.03 359.60 347.97 298.45 Gross Profit 1,165.26 1,244.35 1,145.40 1,082.97 886.24 775.57 647.56 692.18 712.46 656.79 555.55 GP Margin 68.85% 69.49% 68.72% 70.34% 71.45% 70.12% 66.92% 66.67% 66.46% 65.37% 65.05% Total Expenditure 1,465.41 1,540.71 1,381.85 1,213.81 1,022.67 985.01 891.03 906.73 917.40 836.83 688.80 Power & Fuel Cost - 55.31 50.61 42.78 36.89 34.75 28.49 26.62 23.12 21.72 20.39 % Of Sales - 3.09% 3.04% 2.78% 2.97% 3.14% 2.94% 2.56% 2.16% 2.16% 2.39% Employee Cost - 350.55 321.15 294.95 272.88 255.32 231.26 220.34 216.05 181.41 139.64 % Of Sales - 19.57% 19.27% 19.16% 22.00% 23.09% 23.90% 21.22% 20.15% 18.06% 16.35% Manufacturing Exp. - 244.20 195.91 184.62 130.30 114.61 106.86 101.47 96.11 84.80 52.60 % Of Sales - 13.64% 11.75% 11.99% 10.51% 10.36% 11.04% 9.77% 8.96% 8.44% 6.16% General & Admin Exp. - 132.67 122.71 107.50 98.28 128.33 110.90 109.03 116.21 102.31 90.21 % Of Sales - 7.41% 7.36% 6.98% 7.92% 11.60% 11.46% 10.50% 10.84% 10.18% 10.56% Selling & Distn. Exp. - 146.97 111.33 83.19 76.02 89.28 62.75 70.53 73.22 55.89 50.99 % Of Sales - 8.21% 6.68% 5.40% 6.13% 8.07% 6.48% 6.79% 6.83% 5.56% 5.97% Miscellaneous Exp. - 64.55 58.84 44.02 54.23 32.31 30.58 32.70 33.09 42.73 50.99 % Of Sales - 3.60% 3.53% 2.86% 4.37% 2.92% 3.16% 3.15% 3.09% 4.25% 4.28% EBITDA 227.09 250.10 284.84 325.91 217.63 120.98 76.70 131.48 154.66 167.93 165.20 EBITDA Margin 13.42% 13.97% 17.09% 21.17% 17.55% 10.94% 7.93% 12.66% 14.43% 16.71% 19.34% Other Income 14.70 17.38 2.62 6.71 9.05 4.79 6.71 8.15 6.10 4.14 1.74 Interest 47.59 37.80 25.27 17.43 22.22 26.25 21.09 23.51 6.16 12.15 10.34 Depreciation 95.32 87.98 70.60 78.95 73.12 70.81 71.56 67.71 63.27 60.63 47.11 PBT 110.41 141.70 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 99.29 109.48 Tax 25.10 36.58 50.23 81.71 38.96 4.46 -6.40 7.23 13.88 17.00 26.67 Tax Rate 22.73% 23.87% 26.22% 34.59% 29.66% 15.53% 69.26% 14.93% 15.20% 17.12% 24.36% PAT 85.31 116.64 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 82.29 82.81 PAT before Minority Interest 85.31 116.64 141.36 154.52 92.39 24.25 -2.84 41.20 77.46 82.29 82.81 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.04% 6.51% 8.48% 10.04% 7.45% 2.19% -0.29% 3.97% 7.23% 8.19% 9.70% PAT Growth -24.05% -17.49% -8.52% 67.25% 280.99% - - -46.81% -5.87% -0.63% EPS 9.25 12.65 15.33 16.76 10.02 2.63 -0.31 4.47 8.40 8.93 8.98

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,773.21 1,817.29 1,668.61 1,540.75 1,241.53 1,106.58 968.45 1,041.94 1,074.77 1,008.12 857.32 Net Sales Growth 2.17% 8.91% 8.30% 24.10% 12.20% 14.26% -7.05% -3.05% 6.61% 17.59% Cost Of Goods Sold 561.49 559.18 521.29 456.79 354.10 330.43 320.25 347.83 361.27 350.01 300.44 Gross Profit 1,211.72 1,258.10 1,147.32 1,083.97 887.42 776.15 648.19 694.11 713.49 658.12 556.87 GP Margin 68.33% 69.23% 68.76% 70.35% 71.48% 70.14% 66.93% 66.62% 66.39% 65.28% 64.95% Total Expenditure 1,573.42 1,580.87 1,382.57 1,214.50 1,023.20 985.74 891.80 910.37 920.27 840.17 691.81 Power & Fuel Cost - 56.00 50.61 42.78 36.89 34.75 28.49 26.62 23.12 21.72 20.39 % Of Sales - 3.08% 3.03% 2.78% 2.97% 3.14% 2.94% 2.55% 2.15% 2.15% 2.38% Employee Cost - 361.93 322.58 296.28 274.02 256.51 231.66 220.91 216.67 181.87 140.04 % Of Sales - 19.92% 19.33% 19.23% 22.07% 23.18% 23.92% 21.20% 20.16% 18.04% 16.33% Manufacturing Exp. - 247.42 195.91 184.62 130.32 114.63 107.07 101.94 96.38 85.18 52.92 % Of Sales - 13.61% 11.74% 11.98% 10.50% 10.36% 11.06% 9.78% 8.97% 8.45% 6.17% General & Admin Exp. - 137.54 121.88 106.75 97.57 127.76 110.92 110.04 116.40 102.56 90.39 % Of Sales - 7.57% 7.30% 6.93% 7.86% 11.55% 11.45% 10.56% 10.83% 10.17% 10.54% Selling & Distn. Exp. - 149.45 111.33 83.19 76.02 89.28 62.75 70.53 73.22 55.89 51.00 % Of Sales - 8.22% 6.67% 5.40% 6.12% 8.07% 6.48% 6.77% 6.81% 5.54% 5.95% Miscellaneous Exp. - 69.34 58.95 44.10 54.28 32.38 30.66 32.49 33.20 42.94 51.00 % Of Sales - 3.82% 3.53% 2.86% 4.37% 2.93% 3.17% 3.12% 3.09% 4.26% 4.27% EBITDA 199.79 236.42 286.04 326.25 218.33 120.84 76.65 131.57 154.50 167.95 165.51 EBITDA Margin 11.27% 13.01% 17.14% 21.17% 17.59% 10.92% 7.91% 12.63% 14.38% 16.66% 19.31% Other Income 7.60 18.72 2.63 3.42 9.06 4.80 6.70 8.05 5.93 4.03 1.71 Interest 54.26 39.01 25.27 14.14 22.26 26.25 21.09 23.51 6.21 12.39 10.58 Depreciation 106.92 91.87 70.61 78.96 73.13 70.82 71.57 67.71 63.28 60.66 47.09 PBT 57.74 124.27 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 98.93 109.55 Tax 28.34 38.79 50.54 81.77 38.95 4.45 -6.41 7.24 13.87 16.99 26.73 Tax Rate 49.08% 28.56% 26.22% 34.56% 29.51% 15.58% 68.85% 14.96% 15.25% 17.17% 24.40% PAT 29.40 98.46 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 81.94 82.81 PAT before Minority Interest 32.06 97.00 142.25 154.80 93.05 24.12 -2.90 41.16 77.06 81.94 82.81 Minority Interest 2.66 1.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.66% 5.42% 8.53% 10.05% 7.49% 2.18% -0.30% 3.95% 7.17% 8.13% 9.66% PAT Growth -74.07% -30.78% -8.11% 66.36% 285.78% - - -46.59% -5.96% -1.05% EPS 3.19 10.68 15.43 16.79 10.09 2.62 -0.31 4.46 8.36 8.89 8.98

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,126.62 1,027.02 904.30 768.93 680.16 661.08 675.56 651.88 576.45 518.38 Share Capital 18.44 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 1,104.64 1,007.93 885.87 750.50 661.73 642.65 657.13 633.45 558.02 499.95 Non-Current Liabilities 271.74 205.41 156.57 158.29 100.91 116.34 125.27 146.97 66.33 64.58 Secured Loans 203.60 143.50 95.88 96.94 96.93 128.66 123.28 132.31 34.24 9.42 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.64 3.44 Long Term Provisions 33.47 33.33 31.64 66.20 27.08 15.91 23.74 30.87 40.72 15.03 Current Liabilities 595.03 483.21 519.93 408.54 459.17 445.33 416.89 390.37 301.77 258.58 Trade Payables 118.97 126.45 135.32 115.02 166.29 170.70 149.44 164.17 131.01 118.63 Other Current Liabilities 144.66 131.88 139.46 129.33 135.35 117.02 119.32 72.07 57.30 40.88 Short Term Borrowings 250.35 119.45 103.73 117.31 105.98 113.39 109.93 118.36 86.47 73.06 Short Term Provisions 81.05 105.43 141.41 46.88 51.55 44.21 38.19 35.77 26.99 26.02 Total Liabilities 1,993.39 1,715.64 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.22 944.55 841.54 Net Block 732.34 661.46 554.98 569.91 589.62 467.52 488.73 439.75 373.26 339.41 Gross Block 1,554.80 1,406.09 1,236.03 1,177.68 1,126.60 934.50 884.96 769.49 641.58 547.28 Accumulated Depreciation 822.46 744.63 681.05 607.76 536.99 466.98 396.23 329.74 268.32 207.87 Non Current Assets 1,060.39 847.21 714.79 713.81 678.48 686.25 680.57 619.04 483.08 460.11 Capital Work in Progress 114.44 112.57 121.53 68.10 50.70 185.43 135.56 90.63 54.80 62.71 Non Current Investment 51.96 18.90 2.46 2.45 2.45 2.44 2.61 2.82 2.61 0.64 Long Term Loans & Adv. 154.87 52.03 25.98 63.95 26.07 21.75 33.58 66.34 48.02 57.13 Other Non Current Assets 6.78 2.25 9.83 9.39 9.64 9.11 20.09 19.51 4.39 0.21 Current Assets 932.99 868.44 866.01 621.95 561.76 536.50 537.15 570.18 461.46 381.43 Current Investments 7.24 1.00 0.00 0.00 0.00 0.00 0.00 0.00 15.68 0.00 Inventories 310.42 325.99 310.52 237.81 208.24 183.37 193.23 185.04 164.47 146.20 Sundry Debtors 408.02 350.82 297.00 233.58 209.18 194.47 207.83 215.73 187.72 153.64 Cash & Bank 16.94 12.40 19.21 14.05 37.65 36.18 11.81 62.40 12.44 15.28 Other Current Assets 190.36 20.17 34.59 11.89 106.70 122.48 124.28 107.01 81.15 66.31 Short Term Loans & Adv. 130.73 158.06 204.70 124.61 97.59 106.94 117.83 89.38 72.50 61.98 Net Current Assets 337.96 385.23 346.08 213.41 102.59 91.17 120.27 179.81 159.70 122.85 Total Assets 1,993.38 1,715.65 1,580.80 1,335.76 1,240.24 1,222.75 1,217.72 1,189.22 944.54 841.54

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,109.90 1,028.25 904.64 768.99 679.57 660.62 674.98 651.34 576.52 518.80 Share Capital 18.44 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 18.43 Total Reserves 1,087.93 1,009.16 886.21 750.56 661.14 642.19 656.55 632.91 558.08 500.37 Non-Current Liabilities 421.90 205.44 156.60 158.36 101.00 116.42 125.34 147.04 66.28 64.65 Secured Loans 351.73 143.50 95.88 96.94 96.93 128.66 123.28 132.31 34.24 9.42 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.64 3.44 Long Term Provisions 33.68 33.40 31.74 66.35 27.14 15.95 23.77 30.91 40.63 15.04 Current Liabilities 645.50 480.79 518.16 406.92 458.99 445.50 417.36 390.39 302.95 262.12 Trade Payables 153.64 123.46 133.29 113.23 165.60 170.72 149.55 164.03 131.31 119.86 Other Current Liabilities 149.80 132.06 139.61 129.48 135.81 117.13 119.66 72.16 57.38 40.97 Short Term Borrowings 260.52 119.45 103.73 117.31 105.98 113.39 109.93 118.36 87.23 75.38 Short Term Provisions 81.53 105.82 141.53 46.91 51.59 44.26 38.22 35.84 27.03 25.92 Total Liabilities 2,177.90 1,714.48 1,579.40 1,334.27 1,239.56 1,222.54 1,217.68 1,188.77 945.75 845.57 Net Block 954.29 678.25 555.10 569.94 589.74 467.65 488.86 439.89 373.64 339.80 Gross Block 1,780.68 1,422.93 1,236.19 1,177.74 1,126.76 934.65 885.11 769.65 641.95 547.64 Accumulated Depreciation 826.39 744.68 681.09 607.80 537.02 467.00 396.25 329.75 268.32 207.84 Non Current Assets 1,190.06 844.63 712.47 711.75 676.45 684.49 678.73 616.72 481.20 460.22 Capital Work in Progress 124.81 113.60 121.53 68.19 50.70 185.43 135.56 90.63 54.80 62.71 Non Current Investment 1.46 1.46 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.17 Long Term Loans & Adv. 102.45 49.06 25.99 64.01 26.16 22.01 33.92 66.46 48.15 57.31 Other Non Current Assets 7.04 2.26 9.83 9.59 9.83 9.38 20.36 19.72 4.60 0.22 Current Assets 987.84 869.85 866.92 622.53 563.10 538.05 538.96 572.05 464.55 385.36 Current Investments 7.24 1.00 0.00 0.00 0.00 0.00 0.00 0.00 15.68 0.00 Inventories 353.06 325.99 310.52 237.85 208.32 183.45 193.38 186.94 166.69 149.12 Sundry Debtors 406.20 350.94 297.25 233.82 210.14 195.84 209.51 215.68 188.83 155.38 Cash & Bank 24.32 13.34 19.77 14.34 37.93 36.26 11.90 62.59 12.63 15.40 Other Current Assets 197.01 20.18 34.59 11.90 106.71 122.51 124.17 106.85 80.72 65.46 Short Term Loans & Adv. 154.78 158.41 204.80 124.62 97.60 106.96 117.71 89.21 72.06 61.13 Net Current Assets 342.34 389.06 348.77 215.61 104.12 92.55 121.60 181.66 161.60 123.23 Total Assets 2,177.90 1,714.48 1,579.39 1,334.28 1,239.55 1,222.54 1,217.69 1,188.77 945.75 845.58

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 176.78 178.79 173.55 82.17 122.66 132.13 122.76 87.81 112.31 109.91 PBT 141.70 191.59 236.23 131.35 28.71 -9.24 48.43 91.34 99.29 109.48 Adjustment 130.08 120.88 87.12 109.71 99.51 89.34 97.82 64.31 78.78 64.96 Changes in Working Capital -77.42 -72.29 -108.81 -139.14 -1.65 55.66 -13.59 -44.07 -38.46 -39.86 Cash after chg. in Working capital 194.36 240.18 214.54 101.92 126.57 135.75 132.65 111.57 139.61 134.58 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -29.10 -61.38 -40.99 -19.75 -3.92 -3.62 -9.89 -23.77 -27.31 -24.68 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 11.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -301.70 -208.51 -121.41 -66.70 -55.95 -103.76 -135.43 -170.54 -112.62 -88.39 Net Fixed Assets -150.58 -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 -86.39 -84.46 Net Investments -39.30 -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 -17.65 -0.19 Others -111.82 -29.97 -9.62 1.78 1.43 -4.52 24.76 -22.27 -8.58 -3.74 Cash from Financing Activity 122.40 22.81 -44.37 -29.83 -63.95 -16.14 -38.77 132.40 0.17 -20.63 Net Cash Inflow / Outflow -2.52 -6.91 7.77 -14.35 2.76 12.23 -51.44 49.67 -0.15 0.89 Opening Cash & Equivalents 9.99 16.90 9.13 23.48 20.72 8.48 59.92 10.25 10.40 9.52 Closing Cash & Equivalent 7.47 9.99 16.90 9.13 23.48 20.72 8.48 59.92 10.25 10.40

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 156.70 178.83 173.83 82.22 122.85 132.11 122.72 88.64 113.34 109.04 PBT 124.27 192.79 236.57 132.00 28.57 -9.31 48.40 90.94 100.58 109.55 Adjustment 137.55 120.88 87.12 109.76 99.51 89.35 97.67 64.60 76.29 65.21 Changes in Working Capital -87.16 -73.19 -108.79 -139.81 -1.49 55.62 -13.23 -43.25 -36.12 -41.01 Cash after chg. in Working capital 174.66 240.48 214.91 101.94 126.60 135.66 132.83 112.29 140.75 133.75 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -29.49 -61.65 -41.08 -19.72 -3.75 -3.55 -10.12 -23.65 -27.41 -24.71 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 11.53 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -433.83 -208.17 -121.41 -66.69 -55.93 -103.76 -135.43 -170.55 -111.96 -88.41 Net Fixed Assets -150.58 -161.10 -111.78 -68.48 -57.37 -99.41 -160.40 -163.74 -86.39 -84.46 Net Investments -39.30 -17.44 -0.01 0.00 -0.01 0.17 0.21 15.47 -17.65 -0.19 Others -243.95 -29.63 -9.62 1.79 1.45 -4.52 24.76 -22.28 -7.92 -3.76 Cash from Financing Activity 280.43 22.80 -44.37 -29.87 -63.95 -16.14 -38.77 131.57 -1.48 -19.92 Net Cash Inflow / Outflow 3.31 -6.54 8.05 -14.34 2.97 12.22 -51.48 49.66 -0.11 0.70 Opening Cash & Equivalents 10.92 17.47 9.42 23.76 20.80 8.58 60.06 10.40 10.47 9.77 Closing Cash & Equivalent 14.86 10.92 17.47 9.42 23.76 20.80 8.58 60.06 10.36 10.47

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 121.83 111.38 98.13 83.44 73.81 71.74 73.31 70.74 62.55 56.25 ROA 6.29% 8.58% 10.60% 7.17% 1.97% -0.23% 3.42% 7.26% 9.21% 10.57% ROE 10.85% 14.64% 18.47% 12.75% 3.62% -0.43% 6.21% 12.61% 15.03% 16.98% ROCE 12.89% 17.42% 23.31% 15.59% 5.79% 1.24% 7.61% 11.84% 16.78% 20.66% Fixed Asset Turnover 1.21 1.26 1.28 1.08 1.07 1.06 1.26 1.55 1.69 1.68 Receivable days 77.33 70.94 62.89 65.15 66.60 75.87 74.21 67.30 62.00 61.36 Inventory Days 64.86 69.70 64.99 65.63 64.62 71.02 66.28 58.30 56.43 53.67 Payable days 81.96 91.64 100.02 145.00 68.05 71.94 66.81 61.95 56.43 51.50 Cash Conversion Cycle 60.23 48.99 27.86 -14.22 63.17 74.95 73.68 63.66 62.01 63.53 Total Debt/Equity 0.44 0.31 0.27 0.34 0.38 0.45 0.42 0.43 0.24 0.18 Interest Cover 5.05 8.58 14.55 6.91 2.09 0.56 3.06 15.83 9.17 11.59

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 120.02 111.51 98.17 83.45 73.75 71.69 73.25 70.68 62.56 56.30 ROA 4.98% 8.64% 10.63% 7.23% 1.96% -0.24% 3.42% 7.22% 9.15% 10.52% ROE 9.09% 14.72% 18.50% 12.85% 3.60% -0.43% 6.21% 12.55% 14.96% 16.97% ROCE 11.25% 17.50% 23.03% 15.67% 5.78% 1.23% 7.62% 11.80% 16.72% 20.63% Fixed Asset Turnover 1.13 1.25 1.28 1.08 1.07 1.06 1.26 1.55 1.69 1.69 Receivable days 76.04 70.89 62.90 65.26 66.96 76.39 74.23 67.31 62.31 61.67 Inventory Days 68.19 69.62 64.95 65.58 64.61 71.01 66.40 58.84 57.17 54.49 Payable days 90.44 89.88 98.49 143.70 67.82 71.91 66.57 61.79 56.58 52.08 Cash Conversion Cycle 53.79 50.63 29.37 -12.86 63.74 75.49 74.06 64.37 62.91 64.09 Total Debt/Equity 0.59 0.31 0.27 0.34 0.39 0.45 0.42 0.43 0.24 0.19 Interest Cover 4.48 8.63 17.73 6.93 2.09 0.56 3.06 15.64 8.98 11.35

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund

quant mutual fund - quant small cap fund

dsp healthcare fund

hdfc trustee company ltd. a/c hdfc capital builder value fund

franklin india smaller companies fund

mangeshi investment private limited

icici prudential smallcap fund

investor education and protection fund (iepf)

llp

independent director

Annual Reports:

News Update:

Indoco Remedies gets warning letter for Goa facility
17th Dec 2024, 14:25 PM

Earlier, the company had received Official Action Indicated status from USFDA for said facility
Read More
Indoco Remedies enters into strategic distribution partnership with Clarity Pharma, UK
2nd Dec 2024, 17:34 PM

Clarity Pharma has over 25 years of experience in bringing products to market and now services over 4,000 Primary Healthcare customers
Read More
Indoco Remedies gets final ANDA approval from USFDA for Varenicline Tablets
30th Oct 2024, 14:26 PM

Varenicline is used to aid smoking cessation treatment
Read More
Indoco Remedies - Quarterly Results
24th Oct 2024, 12:29 PM

Read More
Indoco Remedies gets USFDA’s approval for Cetirizine Hydrochloride Tablets
4th Oct 2024, 15:08 PM

Cetirizine Hydrochloride Tablets USP, 10 mg will be manufactured by the company, at their manufacturing facility located at Goa
Read More

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532612 | NSE: INDOCO

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Indoco Remedies Ltd.

Pharmaceuticals & Drugs - Global

BSE: 532612 | NSE: INDOCO

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: